TABLE 1.
Clinical features of stage IE/IIE1 gastric diffuse large B‐cell lymphomas treated with first‐line H. pylori eradication therapy
| Clinical characteristics | Response to H. pylori eradication therapy | p * | ||
|---|---|---|---|---|
| Total number (n = 44) | Complete remission (n = 21) | Non‐complete remission (n = 23) | ||
| Age (median, range, years) | 67 (24–100) | 57.5 (34–89) | 70 (24–100) | 0.397 # |
| Gender | ||||
| Women | 25 (56.8%) | 10 (47.6%) | 15 (65.2%) | 0.239 § |
| Men | 19 (43.2%) | 11 (52.4%) | 8 (34.8%) | |
| Endoscopic features, n (%) | ||||
| Ulceration or ulcerated mass | 36 (81.8%) | 15 (71.4%) | 21 (91.3%) | 0.088 § |
| Erosions on giant nodular folds or multiple nodular lesions | 8 (18.2%) | 6 (28.6%) | 2 (8.7%) | |
| Location of tumor (s), n (%) | ||||
| Proximal a or ≥2 components | 15 (34.1%) | 4 (19.0%) | 11 (47.8%) | 0.044 § |
| Distal b | 29 (65.9%) | 17 (81.0%) | 12 (52.2%) | |
| Stage | ||||
| IE | 32 (74.4%) | 15 (75.0%) | 17 (73.9%) | 0.935 § |
| IIE1 | 11 (25.6%) | 5 (25.0%) | 6 (21.6%) | |
| IPI score | ||||
| 0 | 15 (34.1%) | 10 (47.6%) | 5 (21.7%) | 0.10 § |
| 1 | 27 (61.4%) | 11 (52.4%) | 16 (69.6%) | |
| 2 | 2 (4.5%) | 0 (0%) | 2 (8.7%) | |
a
Proximal: Middle body, upper body, fundus, or cardia.
b
Distal: Antrum, angle, or lower body.
*
P: comparison of discrete variables between complete remission cases and non‐complete remission cases.
#
P values (two‐sided) were calculated using the Student's t‐test.
§
P values (two sided) were calculated using the chi‐squared test or the Fisher’s exact test.